Latest news
Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety - STATSTAT · Wed, 05 Aug 2026 17:48:28 GMTFDA advisers reject evidence for Duchenne heart therapy - Muscular Dystrophy NewsMuscular Dystrophy News · Tue, 04 Aug 2026 17:04:06 GMTStockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Mon, 03 Aug 2026 00:49:26 GMTCAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - TradingViewTradingView · Fri, 31 Jul 2026 17:42:39 GMTDuchenne Families Face a Three-Week Wait After FDA Advisers Rejected the Heart Therapy Evidence - Medical DailyMedical Daily · Thu, 30 Jul 2026 07:00:00 GMTFDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute - Fierce BiotechFierce Biotech · Wed, 29 Jul 2026 07:00:00 GMTFDA expert panel recommends against approval of Capricor’s Duchenne drug - STATSTAT · Wed, 29 Jul 2026 07:00:00 GMT